Headhunting and Stoicism: What can a headhunter do to make their job easier?
It is no secret that the headhunting industry has an exceptionally high turnover rate, roughly around 40%. This stands in stark contrast to the UK average turnover rate of 15-17%, and is 10% higher than similar occupations like Sales and Marketing positions. There are ample discussions about how an employer can solve staff retention problems. For instance, employers can […]
5 Top Tips for Phone Interview Preparation
One of the most common mistakes with phone interviews is underestimating them. Phone interviews are just as important as any other interview, employers can’t see your face so your personality will need to shine through the call. Often candidates will not address phone interviews with the same seriousness as an in person interview. Below are […]
Movers & Shakers: Q3 & Q4 2021 – Life Science & CRO
Mantell Associates Life Sciences division works with the Biotech, Pharmaceutical and Contract Research Organisations across the globe placing Junior to Senior level professionals with companies over a number of different therapeutic areas such as Oncology, Neurology, Dermatology, with early stage start up Biotech companies as well as some of the biggest Pharmaceutical names in the […]
Movers & Shakers: Q3 & Q4 2021 – Small Molecule
The Small Molecule CDMO team here at Mantell Associates is recognised as the ‘go-to’ partner within this niche space, with an unprecedented track record of placing professionals from Mid-Senior through to C-Suite & Board appointments. As a team we cover all areas from; Small Molecule API’s, Dosage Forms, Peptides, Oligonucleotides & other chemical entities. The […]
Movers & Shakers: Q3 & Q4 2021 – Large Molecule
The Large Molecule CDMO arm of Mantell Associates covers all appointments within Contract Development and Manufacturing Organisations for new & existing Biological entities, including Vaccines, Cell & Gene Therapy, Biosimilars, Monoclonal Antibodies and Recombinant Proteins. This market is growing rapidly and has been amplified by the pandemic with COVID-19 vaccine production ramped up. The first […]
Movers & Shakers: Q3 & Q4 2021 – Life Science Consulting
Mantell Associates Life Sciences division works with the Biotech, Pharmaceutical and Contract Research Organisations across the globe placing Junior to Senior level professionals with companies over a number of different therapeutic areas such as Oncology, Neurology, Dermatology, with early stage start up Biotech companies as well as some of the biggest Pharmaceutical names in the […]
Neuroscience & The Pharmaceutical Industry
Neuroscience within the pharmaceutical and biotechnology industry has been a hugely controversial subject for many years now. The retreat of Large Biopharma from neuroscience has been continuous for the last decade, this is due to low drug development success rates and several expensive late-stage clinical failures. This has led to several big pharmaceutical companies to […]
What the Future Holds for Cell and Gene Therapy
Unlike many other medical approaches, cell and gene therapies (CGTs) have the potential to be a one-time cure treatment in the future for conditions like multiple, ALS, Haemophilia, Cystic Fibrosis, Cancer, HIV, MS and many more. The concept of CGTs initially rose in the early 60s and early 70s and turning this concept into a therapeutic […]
An Analysis into the Impact of the Ukraine Invasion on the Pharmaceutical Industry
In the early dawn of February 24th, Russian President Vladimir Putin launched what was to become the largest full-scale invasion in Europe since World War II. 6,000 Russian troops marched into Ukraine, signalling the start of a war which has no clear end in sight. Since then, the general Ukrainian population has been mobilised […]